Treatment and Outcome Analysis of 205 Patients with Multidrug-resistant Tuberculosis (Q21563671)

6 February 2023

Valerie Laurel

2

Valerie

Laurel

1 reference

6 February 2023

Matthew J. Strand

3

Matthew J

Strand

1 reference

6 February 2023

Julanie F. Chan

4

Julanie F

Chan

1 reference

6 February 2023

Mai-Lan N. Huynh

5

Mai-Lan N

Huynh

1 reference

6 February 2023

Marian Goble

6

Marian

Goble

1 reference

6 February 2023

Michael D. Iseman

7

Michael D

Iseman

1 reference

American Journal of Respiratory and Critical Care Medicine

6 February 2023

language of work or name

English

0 references

publication date

15 May 2004

0 references

published in

0 references

volume

169

0 references

issue

10

0 references

page(s)

1103-1109

0 references

cites work

Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

The treatment of multidrug-resistant tuberculosis in Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Improved outcomes for patients with multidrug-resistant tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Predictors and outcome of multidrug-resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Pulmonary resection for multi-drug resistant tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Bacteriostatic and bactericidal activity of ciprofloxacin and ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Moxifloxacin (BAY12-8039), a new 8-methoxyquinolone, is active in a mouse model of tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Randomized controlled trial of a drug regimen that includes ciprofloxacin for the treatment of pulmonary tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Comparative roles of levofloxacin and ofloxacin in the treatment of multidrug-resistant tuberculosis: preliminary results of a retrospective study from Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

The bactericidal activity of moxifloxacin in patients with pulmonary tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

Surgical management of resistant mycobacterial tuberculosis and other mycobacterial pulmonary infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

Multidrug-resistant tuberculosis

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

Short-course therapy of acute cystitis: a brief review of therapeutic strategies

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

In vitro and in vivo activities of moxifloxacin and clinafloxacin against Mycobacterium tuberculosis.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

Fluoroquinolone action against clinical isolates of Mycobacterium tuberculosis: effects of a C-8 methoxyl group on survival in liquid media and in human macrophages

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

Development of fluoroquinolones as first-line drugs for tuberculosis--at long last!

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

Tuberculosis therapy: past, present and future.

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200308-1159OC

7 January 2021

10.1164/RCCM.200308-1159OC

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017

1 reference

Consolidated OpenCitations Corpus – April 2017